346 related articles for article (PubMed ID: 32229702)
1. Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model.
Aflatounian A; Edwards MC; Rodriguez Paris V; Bertoldo MJ; Desai R; Gilchrist RB; Ledger WL; Handelsman DJ; Walters KA
J Endocrinol; 2020 Jun; 245(3):381-395. PubMed ID: 32229702
[TBL] [Abstract][Full Text] [Related]
2. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
Xiong T; Rodriguez Paris V; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA
Am J Physiol Endocrinol Metab; 2022 Aug; 323(2):E145-E158. PubMed ID: 35658542
[TBL] [Abstract][Full Text] [Related]
3. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.
Caldwell ASL; Edwards MC; Desai R; Jimenez M; Gilchrist RB; Handelsman DJ; Walters KA
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3334-E3343. PubMed ID: 28320971
[TBL] [Abstract][Full Text] [Related]
5. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model.
Cox MJ; Edwards MC; Rodriguez Paris V; Aflatounian A; Ledger WL; Gilchrist RB; Padmanabhan V; Handelsman DJ; Walters KA
Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32301482
[TBL] [Abstract][Full Text] [Related]
6. Investigating GABA Neuron-Specific Androgen Receptor Knockout in two Hyperandrogenic Models of PCOS.
Sucquart IE; Coyle C; Rodriguez Paris V; Prescott M; Glendining KA; Potapov K; Begg DP; Gilchrist RB; Walters KA; Campbell RE
Endocrinology; 2024 May; 165(7):. PubMed ID: 38788194
[TBL] [Abstract][Full Text] [Related]
7. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
8. Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model.
Sucquart IE; Nagarkar R; Edwards MC; Rodriguez Paris V; Aflatounian A; Bertoldo MJ; Campbell RE; Gilchrist RB; Begg DP; Handelsman DJ; Padmanabhan V; Anderson RA; Walters KA
Endocrinology; 2021 May; 162(5):. PubMed ID: 33522579
[TBL] [Abstract][Full Text] [Related]
9. Androgens in polycystic ovary syndrome: lessons from experimental models.
Walters KA
Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):257-63. PubMed ID: 26866639
[TBL] [Abstract][Full Text] [Related]
10. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.
Venken K; De Gendt K; Boonen S; Ophoff J; Bouillon R; Swinnen JV; Verhoeven G; Vanderschueren D
J Bone Miner Res; 2006 Apr; 21(4):576-85. PubMed ID: 16598378
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor actions on AgRP neurons are not a major cause of reproductive and metabolic impairments in peripubertally androgenized mice.
Kerbus RI; Decourt C; Inglis MA; Campbell RE; Anderson GM
J Neuroendocrinol; 2024 Mar; 36(3):e13370. PubMed ID: 38344844
[TBL] [Abstract][Full Text] [Related]
12. High level of C-type natriuretic peptide induced by hyperandrogen-mediated anovulation in polycystic ovary syndrome mice.
Wang X; Wang H; Liu W; Zhang Z; Zhang Y; Zhang W; Chen Z; Xia G; Wang C
Clin Sci (Lond); 2018 Apr; 132(7):759-776. PubMed ID: 29535265
[TBL] [Abstract][Full Text] [Related]
13. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.
Zhang Y; Hu M; Yang F; Zhang Y; Ma S; Zhang D; Wang X; Sferruzzi-Perri AN; Wu X; Brännström M; Shao LR; Billig H
J Mol Med (Berl); 2021 Oct; 99(10):1427-1446. PubMed ID: 34180022
[TBL] [Abstract][Full Text] [Related]
14. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
Ryan GE; Malik S; Mellon PL
Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
[TBL] [Abstract][Full Text] [Related]
15. Chronic androgen excess in female mice does not impact luteinizing hormone pulse frequency or putative GABAergic inputs to GnRH neurons.
Coyle CS; Prescott M; Handelsman DJ; Walters KA; Campbell RE
J Neuroendocrinol; 2022 Apr; 34(4):e13110. PubMed ID: 35267218
[TBL] [Abstract][Full Text] [Related]
16. Deletion of Androgen Receptors From Kisspeptin Neurons Prevents PCOS Features in a Letrozole Mouse Model.
Decourt C; Watanabe Y; Evans MC; Inglis MA; Fisher LC; Jasoni CL; Campbell RE; Anderson GM
Endocrinology; 2023 Apr; 164(6):. PubMed ID: 37191144
[TBL] [Abstract][Full Text] [Related]
17. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
[No Abstract] [Full Text] [Related]
18. Androgens and polycystic ovary syndrome.
Nisenblat V; Norman RJ
Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):224-31. PubMed ID: 19390322
[TBL] [Abstract][Full Text] [Related]
19. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
Ji SY; Liu XM; Li BT; Zhang YL; Liu HB; Zhang YC; Chen ZJ; Liu J; Fan HY
Mol Hum Reprod; 2017 Oct; 23(10):698-707. PubMed ID: 28961951
[TBL] [Abstract][Full Text] [Related]
20. Androgen increases klotho expression via the androgen receptor-mediated pathway to induce GCs apoptosis.
Zeng X; Zhong Q; Li M; Liu Y; Long S; Xie Y; Mo Z
J Ovarian Res; 2023 Jan; 16(1):10. PubMed ID: 36641458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
